Norinchukin Bank The raised its holdings in Clorox Co (NYSE:CLX) by 1.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 126,075 shares of the company’s stock after purchasing an additional 2,401 shares during the quarter. Norinchukin Bank The’s holdings in Clorox were worth $18,963,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berkshire Asset Management LLC PA increased its stake in Clorox by 17.6% in the third quarter. Berkshire Asset Management LLC PA now owns 3,119 shares of the company’s stock valued at $469,000 after purchasing an additional 467 shares during the period. Carillon Tower Advisers Inc. increased its stake in Clorox by 82.8% in the second quarter. Carillon Tower Advisers Inc. now owns 109,150 shares of the company’s stock valued at $14,763,000 after purchasing an additional 49,450 shares during the period. Legacy Advisors LLC acquired a new position in Clorox in the third quarter valued at $150,000. Victory Capital Management Inc. increased its stake in Clorox by 0.4% in the second quarter. Victory Capital Management Inc. now owns 105,329 shares of the company’s stock valued at $14,246,000 after purchasing an additional 456 shares during the period. Finally, Raymond James Financial Services Advisors Inc. increased its stake in Clorox by 7.2% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 63,730 shares of the company’s stock valued at $8,620,000 after purchasing an additional 4,281 shares during the period. Institutional investors own 77.71% of the company’s stock.

A number of research analysts have recently issued reports on CLX shares. Atlantic Securities started coverage on shares of Clorox in a research note on Thursday, September 20th. They set a “neutral” rating and a $151.00 price target on the stock. Barclays set a $138.00 price target on shares of Clorox and gave the stock a “hold” rating in a research note on Thursday, November 1st. Deutsche Bank boosted their price target on shares of Clorox from $123.00 to $124.00 and gave the stock a “sell” rating in a research note on Thursday, November 1st. Wells Fargo & Co reiterated a “hold” rating on shares of Clorox in a research note on Wednesday, October 31st. Finally, Argus upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a research note on Tuesday, September 25th. Five analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $141.64.

In related news, COO Dawn C. Willoughby sold 54,205 shares of the business’s stock in a transaction dated Tuesday, November 6th. The shares were sold at an average price of $157.39, for a total transaction of $8,531,324.95. Following the sale, the chief operating officer now owns 37,044 shares of the company’s stock, valued at $5,830,355.16. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Diego J. Barral sold 12,880 shares of the business’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $157.98, for a total transaction of $2,034,782.40. Following the sale, the senior vice president now directly owns 18,603 shares in the company, valued at approximately $2,938,901.94. The disclosure for this sale can be found here. In the last three months, insiders have sold 87,088 shares of company stock worth $13,465,508. 1.40% of the stock is owned by insiders.

Shares of Clorox stock opened at $160.18 on Thursday. Clorox Co has a 52-week low of $113.57 and a 52-week high of $162.18. The company has a current ratio of 1.07, a quick ratio of 0.65 and a debt-to-equity ratio of 3.38. The stock has a market cap of $20.56 billion, a PE ratio of 25.59, a PEG ratio of 3.95 and a beta of 0.28.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.59 by $0.03. The firm had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The firm’s revenue was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.46 earnings per share. Equities analysts anticipate that Clorox Co will post 6.31 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 8th. Investors of record on Wednesday, January 23rd will be issued a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date is Tuesday, January 22nd. Clorox’s dividend payout ratio is currently 61.34%.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2018/11/15/norinchukin-bank-the-acquires-2401-shares-of-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What is a balanced fund?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.